Related Experiment Video

Updated: Jun 1, 2026

Chimeric Antigen Receptor T Cell Manufacturing on an Automated Cell Processor
06:18

Chimeric Antigen Receptor T Cell Manufacturing on an Automated Cell Processor

Published on: August 18, 2023

Oversight and management of a cell therapy clinical trial network: experience and lessons learned

Lemuel A Moyé1, Shelly L Sayre, Lynette Westbrook

  • 1University of Texas School of Public Health, Houston, TX 77030, United States. Lemmoye@msn.com

Contemporary Clinical Trials
|May 28, 2011
PubMed

Insights

The Cardiovascular Cell Therapy Research Network (CCTRN) navigated challenges in cell therapy research amidst safety concerns and ethical debates. Strategies for effective collaboration with oversight bodies were developed to advance cardiovascular disease treatments.

Area of Science:

  • Cardiovascular Medicine
  • Regenerative Medicine
  • Clinical Trial Management

Background:

  • The Cardiovascular Cell Therapy Research Network (CCTRN) was established by the National Heart, Lung, and Blood Institute (NHLBI) to advance cell therapy for cardiovascular diseases.
  • The Network commenced operations during a period of heightened scrutiny for novel therapies, marked by drug recalls and halted gene therapy trials.

Purpose of the Study:

  • To describe the challenges faced by the CCTRN during its initiation phase.
  • To outline strategies for effective engagement with regulatory and oversight bodies.

Main Methods:

  • The article reviews the establishment and initial protocols of the CCTRN.
  • It discusses the complex political and ethical landscape influencing the Network's operations.
  • Effective strategies for managing oversight and communication are detailed.

Main Results:

  • The CCTRN initiated three protocols despite a challenging regulatory and cultural environment.
  • The Network encountered significant vigilance from oversight bodies due to prior safety concerns in related fields.

Conclusions:

  • Ongoing education, open communication, and proactive relationship-building with oversight communities are crucial for the success of cell therapy research networks.
  • These strategies facilitate the advancement of promising new cardiovascular therapies in a regulated environment.

More Related Videos

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics08:50

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics

Published on: August 16, 2024

Human Mesenchymal Stem Cell Processing for Clinical Applications Using a Closed Semi-Automated Workflow09:03

Human Mesenchymal Stem Cell Processing for Clinical Applications Using a Closed Semi-Automated Workflow

Published on: March 17, 2023

Related Concept Videos

Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Therapeutic Drug Monitoring: Overview and Classification01:16

Therapeutic Drug Monitoring: Overview and Classification

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...